News | Robotic Systems | May 28, 2020

Hoag Performs First Robotic Carotid Artery Stenting on West Coast

Robotic surgery makes carotid stent placement safer and more precise 

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an innovative robotic interventional procedure to stent a blockage in the carotid artery and improving blood flow to the brain. 

Christopher Baker, M.D., performs a robotically navigated carotid stenting procedure at  Hoag Memorial Hospital Presbyterian using a Corindus Corpath robotic system.Christopher Baker, M.D., director of interventional neuroradiology at the Pickup Family Neurosciences Institute at Hoag, implanted the stent using a new robotic tool, the CorPath GRX from Corindus, a Siemens Healthineers company. The robot helps physicians guide a wire, stent and balloon through a small incision in the patient’s arm or leg, and up into the patient’s neck artery to place the stent precisely at the site of blockage. This exact placement of the stent also allows less exposure to radiation for both the patient and the physician.

“CorPath is remarkable because I am able to perform a high precision, complex surgery while not being next to the patient,” Baker said. “The use of this technology means a safer, more precise surgery for the patient.”  

Thanks to donor support, Hoag’s Pickup Family Neurosciences Institute is the first site on the West Coast to perform robotic-assisted carotid stenting. Currently, robots are only FDA cleared for use in certain general surgery procedures and in peripheral vascular and interventional cardiology procedures. Baker said the tool will likely also prove invaluable in neuro-endovascular procedures. “Carotid stenting has been around for many years, but the really exciting part is the new ability to improve patient safety through precise control of the micro-tools we use in the arteries supplying the patient’s brain.”
 
As a founding member of Orange County’s designated Comprehensive Stroke Receiving Centers, Hoag’s Neurosciences team helped pioneer many of the advanced processes and specialized methods to optimize outcomes for stroke patients including prevention and reversal of acute stroke.
 
Hoag has also been designated a Center of Excellence in Robotic Surgery (COERS) by the Surgical Review Corp., which recognizes hospitals and surgeons who demonstrate an exceptional commitment and ability to consistently deliver safe, effective, evidence-based care through robotic surgery. 
 
“We are excited to be one of the first to offer this innovative robotic tool to help treat patients with significant carotid artery stenosis,” Baker said. “One cannot overstate how precision robotic-assisted tools improve outcomes and speed recovery for patients undergoing complex, very delicate surgeries and help us save more lives.”     

 

Related Content

Among high-risk, chronic, coronary patients who undergo angioplasty, there were no additional benefits from ticagrelor compared to the current standard of care clopidogrel. #AHA #AHA20 #AHA2020
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to clop
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major